Literature DB >> 22735304

Synthesis and biological activity of simplified belactosin C analogues.

Armin de Meijere1, Vadim S Korotkov, Alexander V Lygin, Oleg V Larionov, Viktor V Sokolov, Tine Graef, Mazen Es-Sayed.   

Abstract

Successful biochemical studies of the natural products belactosin A and C and their acylated congeners have shown a β-lactonecarboxamide moiety to be a possible core structure of powerful proteasome inhibitors. As a part of further investigations, variously decorated simplified β-lactonecarboxamides have been synthesized in order to understand structure-biological activity relations in detail, to find ways of improving their biological activity and stability and to reduce the complexity of their preparation. Biological tests showed that the best compounds possess a high potential against phytopathogenic fungi in the greenhouse.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22735304     DOI: 10.1039/c2ob25586c

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  4 in total

1.  Total synthesis and absolute stereochemistry of the proteasome inhibitors cystargolides A and B.

Authors:  Rodolfo Tello-Aburto; Liam P Hallada; Doleshwar Niroula; Snezna Rogelj
Journal:  Org Biomol Chem       Date:  2015-09-24       Impact factor: 3.876

Review 2.  Heterocyclic N-Oxides - An Emerging Class of Therapeutic Agents.

Authors:  A M Mfuh; O V Larionov
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

3.  Natural product scaffolds as inspiration for the design and synthesis of 20S human proteasome inhibitors.

Authors:  Grace E Hubbell; Jetze J Tepe
Journal:  RSC Chem Biol       Date:  2020-09-16

4.  Cystargolide-based amide and ester Pz analogues as proteasome inhibitors and anti-cancer agents.

Authors:  Carlos R Viera; Bradley T Stevens; Talysa Viera; Cameron Zielinski; Lee A Uranga; Snezna Rogelj; Praveen L Patidar; Rodolfo Tello-Aburto
Journal:  R Soc Open Sci       Date:  2022-09-28       Impact factor: 3.653

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.